Prudential Financial
CERE

Prudential Financial’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Prudential Financial’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,099
Closed -$216K – 2823
2024
Q1 		$216K Hold
5,099
– – ﹤0.01% 2451
2023
Q4 		$216K Buy
+5,099
New +$147K ﹤0.01% 2418
2023
Q1 		– Sell
-28,164
Closed -$888K – 2686
2022
Q4 		$888K Buy
28,164
+795
+3% +$22.4K ﹤0.01% 1768
2022
Q3 		$773K Buy
27,369
+10,800
+65% +$322K ﹤0.01% 1875
2022
Q2 		$438K Buy
16,569
+2,090
+14% +$59.3K ﹤0.01% 2189
2022
Q1 		$507K Buy
+14,479
New +$423K ﹤0.01% 2200
2021
Q4 		– Sell
-10,500
Closed -$310K – 2706
2021
Q3 		$310K Buy
+10,500
New +$295K ﹤0.01% 2304

Other funds holding CERE

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Prudential Financial's CERE Position: Q2 2024 in Review

Prudential Financial sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q2 2024, closing a stake of 5,099 shares — an estimated $216K sold.

Prudential Financial first reported a position in CERE in Q3 2021 and held it in 7 quarters. The position peaked at $888K in Q4 2022. 231 funds tracked by Wall St. Rank hold CERE as of Q2 2024.

  • Prudential Financial reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Prudential Financial sold 5,099 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q2 2024, an estimated $216K.
  • Prudential Financial first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
  • Prudential Financial's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $888K in Q4 2022.
  • 231 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q2 2024.

Based on Prudential Financial's 13F filing for Q2 2024, filed 13 Aug 2024.